Curing Parkinson's: The Alternative Approach - Is There Money To Be Made? [View article]
mpc723,
We represent ISCO as their investor relations firm and wanted to weigh in on your statement. ISCO does have its own intellectual property, covering the creation and differentiation of many types of stem cells including parthenogenesis and iPS. As of April 13, 2012, the company has 90 pending patent applications across eight patent families and 3 pending patents related to its skin care products.
One of the main reasons ISCO licenses all of ACTC’s patents in the field of Parthenogenesis is to prevent Advanced Cell Technology from licensing their methods to competitors. As noted on the company’s website, ISCO protects its technology worldwide by filing patent applications covering specific pluripotent hpSC lines, methods to produce new hpSC lines, and various differentiation methods for research, therapeutic, and commercial uses.
If you have any questions regarding ISCO’s IP, feel free to reach out to our team.
BioMedical Technology Solutions (BMTL.OB) Receives Russian Patent for Demolizer® II Technologies [View instapost]
We simply offered coverage of the news back in 2010, as we often highlight various public companies throughout the day. Sorry, but our team is not current with this company or its future prospects.
Curing Parkinson's: The Alternative Approach - Is There Money To Be Made? [View article]
We represent ISCO as their investor relations firm and wanted to weigh in on your statement. ISCO does have its own intellectual property, covering the creation and differentiation of many types of stem cells including parthenogenesis and iPS. As of April 13, 2012, the company has 90 pending patent applications across eight patent families and 3 pending patents related to its skin care products.
One of the main reasons ISCO licenses all of ACTC’s patents in the field of Parthenogenesis is to prevent Advanced Cell Technology from licensing their methods to competitors. As noted on the company’s website, ISCO protects its technology worldwide by filing patent applications covering specific pluripotent hpSC lines, methods to produce new hpSC lines, and various differentiation methods for research, therapeutic, and commercial uses.
If you have any questions regarding ISCO’s IP, feel free to reach out to our team.
Bullfrog Gold Corp. (BFGC) Kicks Off Third Round Of Drilling At Newsboy Gold And Silver Project In Arizona [View instapost]
Lifevantage Corp. (LFVN) Video Chart for Friday, August 19, 2011 [View instapost]
BioMedical Technology Solutions (BMTL.OB) Receives Russian Patent for Demolizer® II Technologies [View instapost]
First Titan Corp. (FTTN) CEO To Meet With Intrepid Drilling Regarding Partnership [View instapost]
Glowpoint Inc. (GLOW) Receives Approval to Begin Trading on NYSE Amex Stock Exchange [View instapost]
Viaspace, Inc.’s (VSPC.OB) Giant King Grass Shows Huge Success and Potential in a Recent Status Update [View instapost]
Regards,
QS
Universal Detection Technology (UNDT.OB) Unveils Rapid Mold Detector [View instapost]